President & Chief Medical Officer
Bobby Azamian is the Founder, President and Chief Medical Officer of Metavention. Bobby joined Versant Ventures in 2011, and while at Versant founded Metavention and served as its first President and Chief Executive Officer. Prior to joining Versant, Bobby was a Senior Associate at Third Rock Ventures, where he was actively involved in the building and launch of the firm’s first medical device companies. Previously, Bobby completed residency in internal medicine and practiced as a hospitalist at Brigham and Women’s Hospital while on the faculty of Harvard Medical School. Bobby holds an MD from the Harvard-MIT Division of Health Sciences and Technology; a DPhil in Chemistry from Oxford University as a Rhodes Scholar; and a BA in Physics from Rice University.